
As wearable ECG technology advances, cardiac safety studies in clinical trials are evolving to capture richer, continuous heart data while reducing patient burden.
CEO of Vivalink
As wearable ECG technology advances, cardiac safety studies in clinical trials are evolving to capture richer, continuous heart data while reducing patient burden.
What is next for DCTs after acceleration from COVID-19?
Published: September 16th 2022 | Updated: